Optical Frequency Domain Imaging (OFDI) in Dermatology

Status Withdrawn

Clinical Trial Summary

This is a pilot exploratory study. The goal of this study is to evaluate a new imaging tool, optical frequency domain imaging (OFDI), to reveal the microvascular morphology of capillary malformations.

Clinical Trial Description

The subject population will be composed of 8 subjects meeting the inclusion and exclusion criteria. Up to 8 subjects may be enrolled for the study after obtaining written, informed consent prior to participation in the study. Recruitment will be performed by direct advertisement to subjects inside and outside Brigham and Women's Hospital (BWH), including the BWH dermatology clinic. The study patients will be managed using standard of care in practice at the BWH dermatology clinic. The study will be conducted at Brigham and Women's Hospital Dermatology Clinic where the pulsed dye laser is housed.

Patients referred to the BWH dermatology clinic will be eligible for recruitment. The study nurse/staff involved in patient enrollment will be familiar with the care of this type of patients. The medical history of these patients will be examined to determine if the study eligibility requirements are met. If the patient is selected as a potential subject, a letter will be sent about 7 days prior to their scheduled exam to ask if they would care to participate. This time frame should allow time for the patient to consider study participation. ;

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01438047
Study type	Observational
Source	Massachusetts General Hospital
Contact
Status	Withdrawn
Phase	N/A
Start date	September 2010
Completion date	September 2012

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT00782483` - Personalized Interactive Laser Therapy of Port Wine Stain	N/A
Completed	`NCT03948997` - The Role of Angiogenesis-related Pathways in the Development of Port Wine Stains	N/A
Completed	`NCT01364857` - French National Cohort of Children With Port Wine Stain	N/A
Withdrawn	`NCT00969397` - Combined Use of Pulsed Dye Laser and Topical Antiangiogenic Agents for Treatment of Port Wine Stain Birthmarks	Phase 1/Phase 2
Completed	`NCT00800722` - A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks.	Phase 1
Completed	`NCT00585247` - Combining Topical Imiquimod 5% Cream With a Pulsed Dye Laser to Treat Port Wine Stain Birthmarks	N/A
Active, not recruiting	`NCT00247299` - Evaluation and Optimization of the Technical and Clinical Performance of the Lumenis ONE Platform	N/A
Completed	`NCT00580736` - Optical Clearing of the Skin in Conjunction With Laser Treatments	Phase 1
Completed	`NCT00540566` - Optical Biopsy of Human Skin in Conjunction With Laser Treatment
Withdrawn	`NCT02035319` - Effect of Laser Treatment on Capillary Malformations	N/A
Withdrawn	`NCT01166919` - Pilot Study on the Use of the Matrix Radiofrequencyfor Treatment of Port Wine Stain Birthmarks	Phase 1
Completed	`NCT00830466` - A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks.	Phase 1
Completed	`NCT00540371` - Dynamic Epidermal Cooling During Pulsed Dye Laser Treatment of Port Wine Stain Birthmark at High Fluences
Completed	`NCT01333553` - Monitoring the Response of Port Wine Stain Birthmarks to Laser Therapy With Wide-field Functional Imaging Technologies
Withdrawn	`NCT00580944` - Combined Alexandrite and Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks	Phase 1